In patients with LAM not taking mTOR inhibitors, percent predicted one second forced expiratory volume (%FEV1) negatively correlated with Gal-3 levels, (Figure 6G and Figure 6—source data 2 and 3). The gene discussed is MTOR; the disease is lymphangioleiomyomatosis.